Stock listing
NSE:PFIZER Pfizer Limited Share Price
Home listing (NSE) of Pfizer Limited
Follow Pfizer Limited into a list and get an email when it puts out news.
Share price · NSE:PFIZER
₹3,856.00 INR +14.20 (+0.4%)
Close on Nov 20, 2026
- Day range
- ₹3,816.00 – ₹3,872.00 INRNov 20, 2026
- Volume
- 13,804 sharesNov 20, 2026
- Market cap
- ₹176.4B INRAt the close on Nov 20, 2026 · price × 45.75M shares outstanding
- 52-week range
- ₹3,589.00 – ₹5,257.00 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹189.1M INRMedian day 21,057 shares · 3 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:PFIZER · Home | ₹3,856.00 INR | +14.20 (+0.4%) | 13,804 | ₹3,850.30 | ₹3,872.00 | ₹3,816.00 | ₹3,841.80 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:PFIZER · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹3,856.00 | +14.20 | +0.4% | ₹3,850.30 | ₹3,872.00 | ₹3,816.00 | 13,804 | |
| ₹3,841.80 | +27.80 | +0.7% | ₹3,813.90 | ₹3,858.40 | ₹3,791.00 | 13,177 | |
| ₹3,814.00 | -4.30 | -0.1% | ₹3,831.00 | ₹3,872.90 | ₹3,797.50 | 20,061 | |
| ₹3,818.30 | -29.10 | -0.8% | ₹3,867.00 | ₹3,867.00 | ₹3,802.00 | 8,457 | |
| ₹3,847.40 | -17.00 | -0.4% | ₹3,884.00 | ₹3,885.00 | ₹3,829.50 | 12,637 | |
| ₹3,864.40 | -28.90 | -0.7% | ₹3,909.00 | ₹3,909.00 | ₹3,849.60 | 23,956 | |
| ₹3,893.30 | -24.60 | -0.6% | ₹3,960.00 | ₹3,963.50 | ₹3,875.50 | 23,583 | |
| ₹3,917.90 | +61.90 | +1.6% | ₹3,915.00 | ₹3,959.00 | ₹3,869.00 | 31,261 | |
| ₹3,856.00 | -0.90 | 0.0% | ₹3,869.60 | ₹3,881.90 | ₹3,797.20 | 40,095 | |
| ₹3,856.90 | +22.20 | +0.6% | ₹3,903.90 | ₹3,904.70 | ₹3,835.00 | 23,020 | |
| ₹3,834.70 | +13.10 | +0.3% | ₹3,831.30 | ₹3,944.00 | ₹3,742.10 | 83,301 | |
| ₹3,821.60 | +182.90 | +5.0% | ₹3,670.00 | ₹3,892.90 | ₹3,633.10 | 313,050 | |
| ₹3,638.70 | -49.10 | -1.3% | ₹3,687.80 | ₹3,718.20 | ₹3,613.60 | 55,742 | |
| ₹3,687.80 | -72.00 | -1.9% | ₹3,760.00 | ₹3,776.90 | ₹3,668.10 | 17,119 | |
| ₹3,759.80 | +25.40 | +0.7% | ₹3,749.00 | ₹3,799.00 | ₹3,732.30 | 13,537 | |
| ₹3,734.40 | +24.60 | +0.7% | ₹3,709.80 | ₹3,753.00 | ₹3,685.00 | 12,634 | |
| ₹3,709.80 | +22.60 | +0.6% | ₹3,699.00 | ₹3,718.00 | ₹3,629.20 | 16,960 | |
| ₹3,687.20 | +74.90 | +2.1% | ₹3,612.30 | ₹3,713.90 | ₹3,595.00 | 16,250 | |
| ₹3,612.30 | -76.60 | -2.1% | ₹3,706.70 | ₹3,706.70 | ₹3,589.00 | 19,137 | |
| ₹3,688.90 | -65.80 | -1.8% | ₹3,751.00 | ₹3,756.30 | ₹3,675.00 | 29,568 | |
| ₹3,754.70 | -54.00 | -1.4% | ₹3,808.70 | ₹3,808.70 | ₹3,740.00 | 12,027 | |
| ₹3,808.70 | -5.30 | -0.1% | ₹3,820.00 | ₹3,840.60 | ₹3,796.80 | 15,484 | |
| ₹3,814.00 | +3.20 | +0.1% | ₹3,811.00 | ₹3,840.00 | ₹3,744.00 | 39,469 | |
| ₹3,810.80 | -114.20 | -2.9% | ₹3,925.00 | ₹3,928.20 | ₹3,800.10 | 45,944 | |
| ₹3,925.00 | -128.50 | -3.2% | ₹4,026.00 | ₹4,026.00 | ₹3,900.50 | 73,579 | |
| ₹4,053.50 | +181.10 | +4.7% | ₹3,872.40 | ₹4,123.90 | ₹3,784.40 | 67,758 | |
| ₹3,872.40 | +64.20 | +1.7% | ₹3,809.10 | ₹3,891.90 | ₹3,809.10 | 13,107 | |
| ₹3,808.20 | +58.20 | +1.6% | ₹3,750.00 | ₹3,817.40 | ₹3,738.50 | 15,805 | |
| ₹3,750.00 | -65.10 | -1.7% | ₹3,815.10 | ₹3,817.70 | ₹3,731.00 | 22,215 | |
| ₹3,815.10 | -37.10 | -1.0% | ₹3,870.00 | ₹3,870.10 | ₹3,802.00 | 11,656 | |
| ₹3,852.20 | +10.00 | +0.3% | ₹3,860.00 | ₹3,868.20 | ₹3,826.70 | 21,026 | |
| ₹3,842.20 | -16.70 | -0.4% | ₹3,858.90 | ₹3,878.00 | ₹3,809.60 | 49,211 | |
| ₹3,858.90 | 0.00 | 0.0% | ₹3,858.90 | ₹3,858.90 | ₹3,858.90 | 0 | |
| ₹3,858.90 | -16.40 | -0.4% | ₹3,894.50 | ₹3,894.60 | ₹3,792.10 | 34,585 | |
| ₹3,875.30 | -37.60 | -1.0% | ₹3,916.00 | ₹3,933.80 | ₹3,833.50 | 39,848 | |
| ₹3,912.90 | -55.10 | -1.4% | ₹3,966.10 | ₹3,988.00 | ₹3,888.60 | 174,412 | |
| ₹3,968.00 | -32.80 | -0.8% | ₹4,001.00 | ₹4,028.90 | ₹3,952.00 | 21,087 | |
| ₹4,000.80 | -45.40 | -1.1% | ₹4,060.00 | ₹4,066.00 | ₹3,988.00 | 15,786 | |
| ₹4,046.20 | +20.70 | +0.5% | ₹4,029.90 | ₹4,060.00 | ₹3,998.90 | 18,668 | |
| ₹4,025.50 | +26.60 | +0.7% | ₹4,021.00 | ₹4,050.00 | ₹3,991.00 | 17,586 | |
| ₹3,998.90 | -36.80 | -0.9% | ₹4,050.00 | ₹4,050.00 | ₹3,990.50 | 10,508 | |
| ₹4,035.70 | +33.30 | +0.8% | ₹4,012.50 | ₹4,045.00 | ₹4,000.00 | 16,758 | |
| ₹4,002.40 | -12.40 | -0.3% | ₹4,054.90 | ₹4,054.90 | ₹3,972.70 | 42,189 | |
| ₹4,014.80 | +0.40 | 0.0% | ₹4,000.00 | ₹4,040.00 | ₹3,985.50 | 20,865 | |
| ₹4,014.40 | -27.20 | -0.7% | ₹4,052.00 | ₹4,080.00 | ₹3,955.50 | 37,281 | |
| ₹4,041.60 | -18.60 | -0.5% | ₹4,075.00 | ₹4,091.10 | ₹4,026.20 | 36,144 | |
| ₹4,060.20 | 0.00 | 0.0% | ₹4,060.20 | ₹4,060.20 | ₹4,060.20 | 0 | |
| ₹4,060.20 | -35.20 | -0.9% | ₹4,103.10 | ₹4,123.80 | ₹4,054.00 | 138,685 | |
| ₹4,095.40 | -75.60 | -1.8% | ₹4,175.80 | ₹4,195.10 | ₹4,080.00 | 267,140 | |
| ₹4,171.00 | -139.70 | -3.2% | ₹4,310.70 | ₹4,318.00 | ₹4,158.40 | 125,703 | |
| ₹4,310.70 | -299.00 | -6.5% | ₹4,530.00 | ₹4,580.80 | ₹4,300.00 | 186,580 | |
| ₹4,609.70 | 0.00 | 0.0% | ₹4,609.70 | ₹4,609.70 | ₹4,609.70 | 0 | |
| ₹4,609.70 | -34.00 | -0.7% | ₹4,628.20 | ₹4,667.90 | ₹4,575.00 | 32,739 | |
| ₹4,643.70 | +16.10 | +0.3% | ₹4,680.00 | ₹4,695.00 | ₹4,601.00 | 10,609 | |
| ₹4,627.60 | -38.30 | -0.8% | ₹4,625.30 | ₹4,655.90 | ₹4,614.00 | 9,434 | |
| ₹4,665.90 | -18.50 | -0.4% | ₹4,684.40 | ₹4,707.80 | ₹4,637.00 | 11,992 | |
| ₹4,684.40 | -19.40 | -0.4% | ₹4,705.00 | ₹4,732.10 | ₹4,673.00 | 10,457 | |
| ₹4,703.80 | -36.60 | -0.8% | ₹4,763.90 | ₹4,778.40 | ₹4,690.10 | 26,865 | |
| ₹4,740.40 | -62.10 | -1.3% | ₹4,816.90 | ₹4,819.10 | ₹4,730.00 | 20,922 | |
| ₹4,802.50 | +44.50 | +0.9% | ₹4,761.00 | ₹4,835.30 | ₹4,737.00 | 26,447 | |
| ₹4,758.00 | -123.50 | -2.5% | ₹4,868.00 | ₹4,880.90 | ₹4,750.00 | 24,870 | |
| ₹4,881.50 | -96.70 | -1.9% | ₹5,020.00 | ₹5,020.00 | ₹4,865.00 | 20,411 | |
| ₹4,978.20 | +58.20 | +1.2% | ₹4,980.00 | ₹5,030.00 | ₹4,930.00 | 63,975 | |
| ₹4,920.00 | +0.50 | 0.0% | ₹4,961.30 | ₹4,969.00 | ₹4,870.10 | 297,497 |
Splits
1 split · NSE:PFIZER · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split |
- Ticker
- NSE:PFIZER
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NSE
- Currency
- INR
What changed lately
Latest news release · May 12, 2026
Pfizer: Audited Results - Year ended March 31, 2026
Latest news
Pfizer: Audited Results - Year ended March 31, 2026
May 12, 2026
Closed ₹4,613.50 (-2.4%) on May 13, 2026
Pfizer: Unaudited Results – Quarter ended December 31, 2025
Feb 9, 2026
Closed ₹4,960.80 (+4.1%) on Feb 10, 2026
Press Release Dec 19 2025
Dec 19, 2025
Closed ₹5,093.10 (-0.1%) on Dec 22, 2025
Pfizer: & Cipla Announce Exclusive Marketing and Distribution Partnership for Select Brands in India
Dec 18, 2025
Closed ₹5,097.60 (-0.1%) on Dec 19, 2025
Pfizer Limited on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 4 in the last 12 months · 28 in all · newest May 12, 2026 · oldest 2014
- Decks
- 1 deck · latest Nov 23, 2013
Where Pfizer Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:PFIZER · Home listing · This page | NSE | India | INR |
| BSE:PFIZER | BSE | India | INR |
Valuation
P/E 20.5× against a median of 21.4×: 6th lowest of 11 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹114.5B INR
- P/E
- 20.5×
- EV/sales
- 4.3×
- EV/EBITDA
- 11.8×
- Price/book
- 4.0×
- Gross margin
- 51.2%
- Operating margin
- 34.5%
- Net margin
- 32.4%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Pfizer Limited · NSE:PFIZER | US$1.90B | US$1.24B | 20.5× | 4.3× | 11.8× | 4.0× | 32.4% | 0.0× | n/a |
| Henan Lingrui Pharmaceutial Co., Ltd. Class A · SSE:600285 | US$2.04B | US$1.89B | 16.4× | 3.2× | n/a | 3.9× | 20.9% | 0.0× | n/a |
| Novast Laboratories Ltd · SZSE:301569 | US$2.01B | US$1.80B | 43.0× | 11.9× | n/a | 5.9× | 30.8% | 0.0× | n/a |
| Aurinia Pharmaceuticals Inc · NASDAQ:AUPH | US$1.97B | US$1.92B | 6.3× | 6.0× | n/a | 3.0× | 97.7% | 0.0× | 0.64 |
| Harmony Biosciences Holdings, Inc. · NASDAQ:HRMY | US$1.91B | US$1.29B | 10.7× | 1.3× | 5.4× | 1.8× | 18.1% | 0.1× | 0.57 |
| Alivus Life Sciences Ltd · NSE:ALIVUS | US$1.90B | US$1.80B | 26.3× | 6.2× | 18.1× | 4.9× | 24.9% | 0.0× | n/a |
| Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A · SSE:603707 | US$1.90B | US$1.52B | 29.8× | 2.5× | n/a | 1.8× | 10.4% | 0.0× | n/a |
| Shenzhen Kangtai Biological Products Co. Ltd. Class A · SZSE:300601 | US$1.80B | US$1.74B | 103× | 4.7× | n/a | 1.2× | 4.8% | 0.2× | n/a |
| Shilpa Medicare Limited · NSE:SHILPAMED | US$1.79B | US$1.85B | 50.0× | 9.3× | 33.5× | 6.0× | 18.1% | 0.2× | n/a |
| Dermapharm Holding SE · XETR:DMP | US$1.78B | US$2.88B | 12.4× | 2.2× | 6.9× | 2.9× | 11.1% | 2.0× | n/a |
| Shenyang Xingqi Pharmaceutical Co., Ltd. Class A · SZSE:300573 | US$1.76B | US$1.69B | 14.6× | 4.0× | n/a | 5.2× | 28.6% | 0.0× | n/a |
| Median of the others | US$1.90B | US$1.80B | 21.4× | 4.4× | 12.5× | 3.5× | 19.5% | 0.0× | 0.61 |
Forecasts
Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.
- Price target
- 5321.60 INR · Analysts' mean
- EPS, year to Mar 2027
- 176.90 · 2 analysts
- Revenue, year to Mar 2027
- 26.69B · 4 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Amit Agarwal | Executive Director - Finance & Chief Financial Officer |
| Meenakshi Nevatia | Managing Director |
Board
| Director | Role |
|---|---|
| Pradip Shah | Chairman & Non-Independent Non-Executive Director |
| Amit Agarwal | Executive Director - Finance & Chief Financial Officer |
| Lakshmanan Krishnakumar | Independent Director |
| Meena Ganesh | Independent Director |
| Sonia Singh | Independent Director |
Events
- Next results
- Feb 9, 2027 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q2 2027 | Nov 3, 2026 · Before open | +5.0% |
| Q1 2027 | Jul 28, 2026 · After close | +0.9% |
| Q3 2026 | Feb 9, 2026 · Before open | +3.8% |
| Q2 2026 | Nov 12, 2025 · Before open | +0.4% |
| Q4 2025 | May 19, 2025 · After close | +10.8% |
| Q3 2025 | Jan 31, 2025 · Before open | +0.4% |
| Q2 2025 | Oct 28, 2024 · Before open | −0.7% |
| Q1 2025 | Jul 29, 2024 · Before open | +2.4% |
| Q4 2024 | May 17, 2024 · After close | −0.4% |
| Q3 2024 | Feb 9, 2024 · Before open | −3.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2024 | Oct 28, 2023 · Before open | +0.2% |
| Q3 2023 | Feb 9, 2023 · Before open | +0.0% |
| Q2 2023 | Nov 11, 2022 · Before open | −1.0% |
| Q1 2023 | Aug 5, 2022 · After close | −0.7% |
| Q4 2022 | May 20, 2022 · Before open | +2.2% |
| Q3 2022 | Feb 3, 2022 | −3.3% |
| Quarter to Sep 30, 2021 | Nov 3, 2021 · Before open | −1.1% |
| Quarter to Jun 30, 2021 | Jul 28, 2021 · Before open | +0.1% |
| Quarter to Mar 31, 2021 | May 26, 2021 | −2.3% |
| Quarter to Dec 31, 2020 | Feb 5, 2021 · Before open | +0.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (November 2013) | Merger or acquisition | 19 slides | Nov 23, 2013 |
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.2B | 22.8B | 21.9B | 24.2B | 26.1B | 22.4B | 21.5B | 20.8B | 19.7B | 19.7B |
| Cost of revenue | 13.1B | 8.16B | 7.98B | 8.78B | 9.53B | 8.03B | 7.98B | 7.53B | 7.46B | 8.05B |
| Gross profit | 12.1B | 14.7B | 13.9B | 15.5B | 16.6B | 14.4B | 13.5B | 13.3B | 12.2B | 11.6B |
| Research and development | 275.0M | |||||||||
| Selling, general and administrative | 1.98B | 3.72B | 3.48B | 3.32B | 4.04B | 3.62B | 3.68B | 3.60B | 3.50B | 3.38B |
| Operating income | 8.46B | 10.4B | 9.61B | 11.5B | 11.8B | 10.1B | 9.00B | 8.87B | 8.01B | 7.53B |
| Depreciation and amortization | 577.3M | 607.9M | 622.8M | 1.06B | 1.15B | 1.09B | 1.03B | 713.9M | 662.5M | 629.3M |
| EBITDA | 9.04B | 11.0B | 10.2B | 12.6B | 12.9B | 11.2B | 10.0B | 9.58B | 8.68B | 8.16B |
| Interest expense | 94.8M | 85.0M | 154.3M | 133.9M | 107.0M | 153.9M | 108.5M | 12.9M | 4.20M | 19.6M |
| Income before tax | 9.76B | 10.2B | 7.46B | 8.24B | 7.73B | 6.69B | 6.42B | 6.60B | 5.48B | 5.17B |
| Income tax | 2.53B | 2.48B | 1.95B | 2.00B | 1.60B | 1.71B | 1.33B | 2.31B | 1.88B | 1.80B |
| Net income | 7.22B | 7.68B | 5.51B | 6.24B | 6.13B | 4.98B | 5.09B | 4.29B | 3.60B | 3.37B |
| Earnings per share, basic | 157.92 | 167.79 | 120.51 | 136.38 | 133.89 | 108.77 | 111.29 | 93.78 | 78.70 | 73.61 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.03B | 5.13B | 1.12B | 366.0M | 627.6M | 1.57B | 17.6B | 738.1M | 507.3M | 675.9M |
| Short-term investments | 29.9B | 22.9B | 19.1B | 18.0B | 15.5B | 9.41B | 4.31B | 18.2B | 17.0B | 14.3B |
| Receivables | 1.82B | 1.93B | 1.88B | 2.39B | 1.92B | 2.40B | 3.08B | 3.31B | 3.49B | 2.97B |
| Inventory | 4.73B | 4.76B | 4.34B | 4.34B | 4.18B | 4.49B | 4.35B | 3.87B | 2.97B | 3.22B |
| Current assets | 38.0B | 35.1B | 27.7B | 25.3B | 24.0B | 19.1B | 30.5B | 27.2B | 24.2B | 20.5B |
| Property, plant and equipment | 1.79B | 1.51B | 1.85B | 2.20B | 1.95B | 2.15B | 714.3M | 825.4M | 871.9M | |
| Goodwill | 5.27B | 5.27B | 5.27B | 5.27B | 5.27B | 5.27B | 5.27B | 5.27B | 5.27B | 5.27B |
| Total assets | 49.2B | 49.1B | 42.3B | 40.0B | 39.0B | 32.7B | 44.1B | 39.4B | 36.9B | 32.7B |
| Accounts payable | 2.16B | 1.52B | 1.66B | 2.17B | 2.64B | 2.84B | 4.27B | 4.36B | 4.96B | 32.3M |
| Current liabilities | 6.27B | 5.70B | 5.47B | 6.57B | 8.53B | 7.74B | 8.73B | 8.92B | 9.54B | 7.80B |
| Long-term debt | 25.0M | |||||||||
| Total debt | 702.3M | 1.08B | 945.4M | 1.34B | 1.67B | 1.06B | 1.28B | 25.0M | 25.0M | 25.0M |
| Total liabilities | 7.19B | 6.94B | 6.33B | 7.93B | 10.4B | 8.73B | 10.1B | 9.29B | 10.1B | 8.52B |
| Shareholders' equity | 42.0B | 42.2B | 36.0B | 32.1B | 28.6B | 23.9B | 34.0B | 30.1B | 26.8B | 24.2B |
| Shares outstanding | 45.7M | 45.7M | 45.7M | 45.7M | 45.8M | 45.8M | 45.8M | 45.8M | 45.8M | 45.8M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 11.4B | 6.60B | 2.57B | 3.56B | 6.67B | 4.27B | 3.23B | 978.1M | 3.32B | 3.29B |
| Capital spending | -252.3M | -281.5M | -189.3M | -649.8M | -153.1M | -177.0M | -168.9M | -44.9M | -1.03B | -252.9M |
| Free cash flow | 11.2B | 6.32B | 2.38B | 2.91B | 6.52B | 4.10B | 3.06B | 933.2M | 2.29B | 3.04B |
| Cash from investing | -7.39B | -713.4M | -713.4M | -360.5M | -5.75B | -4.69B | 15.3B | 351.2M | -2.38B | -2.50B |
| Cash from financing | -7.97B | -2.05B | -2.05B | -3.46B | -1.81B | -15.7B | -1.64B | -1.10B | -1.10B | -825.9M |
| Dividends paid | -7.52B | -1.60B | -1.83B | -2.97B | -1.60B | -15.2B | -1.03B | -910.5M | -917.3M | -686.2M |
| Change in cash | 26.0B | 3.83B | 754.0M | -261.6M | -884.5M | -16.1B | 16.9B | 230.8M | -168.6M | -34.7M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Dec 19 2025 | Dec 19, 2025 | Material contract | NSE India |
| Press Release Aug 11 2025 | Aug 11, 2025 | Operations update | NSE India |
| Press Release Feb 09 2023 | Feb 9, 2023 | Management or board change | NSE India |
| Press Release May 26 2021 | May 26, 2021 | Results | NSE India |
| Press Release Nov 02 2020 | Nov 2, 2020 | Other filings | NSE India |
Cap table
Built by 6ix from Pfizer Limited’s releases
- Common shares
- 45,747,732
- Fully diluted
- 45,747,732
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 45,747,732 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 45,747,732 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Amit Agarwal | Executive Director - Finance & Chief Financial Officer · Since at least Sep 23, 2025 |
| Lakshmanan Krishnakumar | Independent Director · Since at least Nov 4, 2026 |
| Meena Ganesh | Independent Director · Since at least Sep 23, 2025 |
| Meenakshi Nevatia | Managing Director · Since at least May 12, 2026 |
| Pradip Shah | Chairman & Non-Independent Non-Executive Director · Since at least Sep 23, 2025 |
| Sonia Singh | Independent Director · Since at least Sep 23, 2025 |
Log in to ask 6ix AI your own questions about Pfizer Limited.